| Q26782039 | 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product |
| Q29248210 | A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease |
| Q53837365 | A High-fat and High-Cholesterol Diet Potentiates Oxidative Damage in Hippocampus of Mice Lacking Apolipoprotein E. |
| Q39513459 | A Strategy for Suppressing Redox Stress within Mitochondria |
| Q48723423 | A multi-ingredient dietary supplement abolishes large-scale brain cell loss, improves sensory function, and prevents neuronal atrophy in aging mice |
| Q39867692 | A novel oxidative stress marker in patients with Alzheimer's disease: dynamic thiol-disulphide homeostasis |
| Q36797166 | A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial |
| Q42321081 | Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration |
| Q40741905 | Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation |
| Q43962738 | Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system |
| Q21285060 | Air pollution, oxidative stress, and Alzheimer's disease |
| Q42487544 | Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells |
| Q44489318 | Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin |
| Q34020000 | Alzheimer's disease is type 3 diabetes-evidence reviewed |
| Q37111515 | Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression |
| Q37946306 | Amyloid-β production: major link between oxidative stress and BACE1. |
| Q39512192 | An acetate prodrug of a pyridinol-based vitamin E analogue |
| Q24611928 | An epigenetic blockade of cognitive functions in the neurodegenerating brain |
| Q42921152 | An okadaic acid-induced model of tauopathy and cognitive deficiency. |
| Q39776832 | An optimized pyrimidinol multifunctional radical quencher. |
| Q53253568 | Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts. |
| Q37172100 | Ascorbic acid and rates of cognitive decline in Alzheimer's disease. |
| Q48328637 | Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE |
| Q44643912 | BACE1 Suppression by RNA Interference in Primary Cortical Neurons |
| Q37090426 | Base excision repair of oxidative DNA damage and association with cancer and aging |
| Q39337905 | Benchmarking the DFT methodology for assessing antioxidant-related properties: quercetin and edaravone as case studies. |
| Q38973131 | Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway. |
| Q47099956 | Bioactivity of Olive Oil Phenols in Neuroprotection. |
| Q34509739 | Biological markers and the treatment of Alzheimer's disease |
| Q37374156 | Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. |
| Q33556189 | Biomarkers in translational research of Alzheimer's disease |
| Q33470625 | Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein |
| Q58613813 | Blue Light Induces Down-Regulation of Aquaporin 1, 3, and 9 in Human Keratinocytes |
| Q28259585 | Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease |
| Q35997881 | Brain metabolic dysfunction at the core of Alzheimer's disease |
| Q28345684 | Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease |
| Q33561710 | CKD associates with cognitive decline |
| Q41814841 | Cardioprotective and neuroprotective roles of oleuropein in olive. |
| Q22242643 | Cardiovascular Risk Factors for Alzheimer's Disease |
| Q34112184 | Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis |
| Q28087030 | Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation |
| Q40903084 | Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo |
| Q43566869 | Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease |
| Q44401653 | Cholesterol storage and tau pathology in Niemann–Pick type C disease in the brain |
| Q43623865 | Cholinergic- and stress-induced signaling activities in cells overexpressing wild-type and mutant presenilin-1. |
| Q37812906 | Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? |
| Q82928114 | Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration |
| Q46818462 | Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation |
| Q35936864 | Combination therapy in Alzheimer's disease: a review of current evidence |
| Q57362618 | Comparative measurements of multicomponent phospholipid mixtures by electrospray mass spectroscopy: relating ion intensity to concentration |
| Q42055242 | Comparison of the inhibition of monoamine oxidase and butyrylcholinesterase activities by infusions from green tea and some citrus peels |
| Q47738165 | Compressional-Puffing Pretreatment Enhances Neuroprotective Effects of Fucoidans from the Brown Seaweed Sargassum hemiphyllum on 6-Hydroxydopamine-Induced Apoptosis in SH-SY5Y Cells |
| Q40841581 | Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal |
| Q79414023 | Convenient and efficient syntheses of 4-hydroxy-2(E)-nonenal and 4-oxo-2(E)-nonenal |
| Q34639502 | Cu(2+) affects amyloid-β (1-42) aggregation by increasing peptide-peptide binding forces |
| Q89661957 | Cyanidin-3-glucoside activates Nrf2-antioxidant response element and protects against glutamate-induced oxidative and endoplasmic reticulum stress in HT22 hippocampal neuronal cells |
| Q33588687 | Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid |
| Q51920410 | Decreased plasma antioxidants in patients with Alzheimer's disease. |
| Q53233486 | Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. |
| Q42872699 | Design, synthesis, and evaluation of an α-tocopherol analogue as a mitochondrial antioxidant |
| Q34147767 | Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease. |
| Q35792238 | Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer's disease |
| Q42495571 | Differential alterations in antioxidant capacity in cells from Alzheimer patients |
| Q35243119 | Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain |
| Q44184688 | Differential modulation of growth and glutathione metabolism in cultured rat astrocytes by 4-hydroxynonenal and green tea polyphenol, epigallocatechin-3-gallate |
| Q84523946 | Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation |
| Q29994789 | Downregulating ANP32A rescues synapse and memory loss via chromatin remodeling in Alzheimer model |
| Q57169774 | Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease? |
| Q42733175 | Early induction of oxidative stress in a mouse model of Alzheimer's disease with heme oxygenase activity |
| Q37243732 | Early stages of oxidative stress-induced membrane permeabilization: a neutron reflectometry study |
| Q57822469 | Effect of smoking cessation on the risk of dementia: a longitudinal study |
| Q74257050 | Effect of temperature on postanoxic, potentially neurotoxic changes of plasma pH and free iron level in newborn rats |
| Q43608637 | Effects of staurosporine, U-73122, wortmannin, 4-hydroxynonenal and sodium azide upon the release of secreted beta-amyloid precursor protein from human platelets in response to thrombin stimulation |
| Q77384419 | Enhanced maze performance and reduced oxidative stress by combined extracts of zingiber officinale and ginkgo biloba in the aged rat |
| Q53261204 | Epidemiologic evidence of oxidative stress in the brain. |
| Q33904779 | Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis |
| Q37576151 | Epoxyeicosatrienoic acids pretreatment improves amyloid β-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes |
| Q43664494 | Estimation of lipid peroxidation of live cells using a fluorescent probe, diphenyl-1-pyrenylphosphine |
| Q34449998 | Exercise attenuates the major hallmarks of aging |
| Q33427066 | Expression of nitrergic system and protein nitration in adult rat brains submitted to acute hypobaric hypoxia. |
| Q60960529 | Four New Depsides Isolated from and Their Significant Nerve-Protective Activities |
| Q73212345 | Free radicals and lipid peroxidation do not mediate beta-amyloid-induced neuronal cell death |
| Q34353302 | Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies |
| Q50205666 | Functional and morphological evaluation of blue light-emitting diode-induced retinal degeneration in mice |
| Q35001322 | Garlic and aging: new insights into an old remedy |
| Q44540942 | Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females |
| Q47784892 | Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease. |
| Q28190140 | Glutamate uptake |
| Q40657727 | H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. |
| Q48233598 | HDAC2 selectively regulates FOXO3a-mediated gene transcription during oxidative stress-induced neuronal cell death |
| Q28200851 | Hohenheim consensus workshop: copper |
| Q41090932 | Hsp70 alters tau function and aggregation in an isoform specific manner |
| Q49129166 | Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules |
| Q34549266 | Hydralazine Modifies Aβ Fibril Formation and Prevents Modification by Lipids in Vitro |
| Q35168684 | Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects |
| Q34174754 | Inactivation and reactivation of the mitochondrial α-ketoglutarate dehydrogenase complex |
| Q43868531 | Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains |
| Q43638880 | Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q34385820 | Inhibitors of Catalase-Amyloid Interactions Protect Cells from β-Amyloid-Induced Oxidative Stress and Toxicity |
| Q46023001 | Inhibitory effect of Poncirus trifoliate on acetylcholinesterase and attenuating activity against trimethyltin-induced learning and memory impairment. |
| Q37602608 | Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. |
| Q43697219 | Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice. |
| Q34658001 | Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease |
| Q36604677 | Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease |
| Q33915441 | Isoprenoids, small GTPases and Alzheimer's disease |
| Q90438495 | Jdp2-deficient granule cell progenitors in the cerebellum are resistant to ROS-mediated apoptosis through xCT/Slc7a11 activation |
| Q34043199 | Lactoferrin as a natural immune modulator |
| Q51946248 | Lead Exposure Biomarkers and Mini-Mental Status Exam Scores in Older Men |
| Q30726891 | Ligand modulation of glial activation: cell permeable, small molecule inhibitors of serine-threonine protein kinases can block induction of interleukin 1 beta and nitric oxide synthase II. |
| Q37802185 | Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress |
| Q38192931 | Lipid integration in neurodegeneration: an overview of Alzheimer's disease |
| Q38378725 | Localization of the noncovalent binding site between amyloid-beta-peptide and oleuropein using electrospray ionization FT-ICR mass spectrometry |
| Q35997878 | Mechanisms of ceramide-mediated neurodegeneration |
| Q35997866 | Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease |
| Q28217483 | Melatonin in Alzheimer's disease and other neurodegenerative disorders |
| Q39310069 | Membrane changes under oxidative stress: the impact of oxidized lipids. |
| Q33908238 | Metabolism and functions of glutathione in brain. |
| Q37428097 | Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease |
| Q48256084 | Methionine in Proteins: It's Not Just for Protein Initiation Anymore |
| Q44026039 | Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro |
| Q35891872 | Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases |
| Q36626374 | Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics |
| Q44470278 | Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum |
| Q26744211 | Modulation of cellular redox homeostasis by the endocannabinoid system |
| Q39712891 | Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production |
| Q28546214 | Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases |
| Q33720596 | Nanoparticle and iron chelators as a potential novel Alzheimer therapy |
| Q36161882 | Natural antioxidants for neurodegenerative diseases |
| Q37363138 | Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease |
| Q35009772 | Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease |
| Q34099466 | Neuronutrition and Alzheimer's disease |
| Q40232590 | Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease. |
| Q37963878 | Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory Processes |
| Q35133792 | Neuroprotective and anti-oxidant effects of caffeic acid isolated from Erigeron annuus leaf. |
| Q34262805 | New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future |
| Q35791943 | Nitration of tau protein is linked to neurodegeneration in tauopathies |
| Q34991505 | Non-cholinergic strategies for treating and preventing Alzheimer's disease |
| Q46964400 | Noncovalent interaction between amyloid-beta-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry |
| Q35878177 | Novel advances in shotgun lipidomics for biology and medicine |
| Q40022648 | Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease |
| Q95856552 | Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress |
| Q34775705 | Nutritional approaches to combat oxidative stress in Alzheimer's disease |
| Q53073171 | Oil Palm Phenolics Inhibit the In Vitro Aggregation of β-Amyloid Peptide into Oligomeric Complexes. |
| Q31680418 | Okadaic acid-induced upregulation of nitrotyrosine and heme oxygenase-1 in rat cortical neuron cultures |
| Q24628912 | Oleuropein in olive and its pharmacological effects |
| Q33996763 | Omega-3 and omega-6 fatty acids suppress ER- and oxidative stress in cultured neurons and neuronal progenitor cells from mice lacking PPT1. |
| Q89862476 | One- and Two-Electron Oxidations of β-Amyloid25-35 by Carbonate Radical Anion (CO3•-) and Peroxymonocarbonate (HCO4-): Role of Sulfur in Radical Reactions and Peptide Aggregation |
| Q43901274 | Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy |
| Q52595131 | Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects. |
| Q28538487 | Oxidation enhances human serum albumin thermal stability and changes the routes of amyloid fibril formation |
| Q38818702 | Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease. |
| Q41351496 | Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice |
| Q36161854 | Oxidative imbalance in Alzheimer's disease |
| Q48491927 | Oxidative neuropathology and putative chemical entities for Alzheimer's disease: neuroprotective effects of salen-manganese catalytic anti-oxidants |
| Q42527636 | Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients |
| Q34659807 | Oxidative stress and the pathogenesis of neurodegenerative disorders |
| Q37928994 | Oxidative stress and β-amyloid protein in Alzheimer's disease |
| Q40737554 | Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme |
| Q35963897 | Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species |
| Q45239582 | Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products |
| Q28214125 | Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease |
| Q47105295 | Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease |
| Q49150383 | Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. |
| Q37276038 | Phosphatidylinositol 3 kinase pathway and 4-hydroxy-2-nonenal-induced oxidative injury in the RPE. |
| Q44555815 | Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. |
| Q28609417 | Plasmalogens: biosynthesis and functions |
| Q47364942 | Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment |
| Q38554910 | Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions |
| Q43557687 | Programmed cell death induced by glutathione depletion in PC 12 cells is blocked by inhibitors of 12 lipoxygenase, but does not appear to be mediated through the formation of 12 HETE derivatives |
| Q39789745 | Progress in the development of new drugs in Alzheimer's disease |
| Q36528165 | Promotion of oxidative lipid membrane damage by amyloid beta proteins |
| Q37105481 | Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J |
| Q59215332 | Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells |
| Q36075555 | Protective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model |
| Q43540892 | Protein oxidation in the brain in Alzheimer's disease |
| Q27014070 | ROS and brain diseases: the good, the bad, and the ugly |
| Q39324761 | Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance |
| Q93197465 | Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy |
| Q40542932 | Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease |
| Q44692839 | Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease |
| Q53246017 | Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. |
| Q40077781 | Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity. |
| Q35040395 | Role of central nervous system insulin resistance in fetal alcohol spectrum disorders |
| Q34400646 | Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment |
| Q35666080 | Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. |
| Q35625434 | Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease |
| Q38357213 | S100B protein and 4-hydroxynonenal in the spinal cord of wobbler mice |
| Q38766074 | SOD3 Ameliorates Aβ25-35-Induced Oxidative Damage in SH-SY5Y Cells by Inhibiting the Mitochondrial Pathway |
| Q25257581 | Shift work as an oxidative stressor |
| Q50007004 | Smoking cessation for the neurologic patient |
| Q49136975 | Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice |
| Q36799584 | Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers |
| Q44321229 | Targets of oxidative stress in yeast sod mutants |
| Q37375228 | Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease |
| Q59794299 | The Chinese herbal formula Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice |
| Q50052210 | The Potential Role of Oxidative Stress in Cardiac Hypertrophy: A Narrative Review. |
| Q60923965 | The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders |
| Q44230756 | The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro |
| Q36325596 | The expanding role of BDNF: a therapeutic target for Alzheimer's disease? |
| Q33763420 | The female sex hormone oestrogen as a neuroprotectant |
| Q35787818 | The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients |
| Q44826656 | The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family |
| Q49065735 | The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats |
| Q73851297 | The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes |
| Q33950398 | The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models |
| Q33971345 | The role of complement in Alzheimer's disease pathology |
| Q26859190 | The role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesium |
| Q48190046 | The synthesis and evaluation of novel hydroxyl substituted chalcone analogs with in vitro anti-free radicals pharmacological activity and in vivo anti-oxidation activity in a free radical-injury Alzheimer's model. |
| Q46448173 | Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. |
| Q35004992 | Undifferentiated and differentiated PC12 cells protected by huprines against injury induced by hydrogen peroxide |
| Q46241120 | Use of liquid chromatography with electrochemical detection for the determination of antioxidants in less common fruits. |
| Q35951646 | Vascular oxidative stress in Alzheimer disease |
| Q42368222 | Vitamin C Status and Cognitive Function: A Systematic Review |
| Q38284940 | Water Extractable Phytochemicals from Peppers (Capsicum spp.) Inhibit Acetylcholinesterase and Butyrylcholinesterase Activities and Prooxidants Induced Lipid Peroxidation in Rat Brain In Vitro |
| Q35829548 | Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies |